Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5 Gastrointestinal 3 Other solid neoplasm 2 Gynecologic 2 Sarcoma 1 CNS 1 Breast 1

Conditions

Interventions

Cyclophosphamide 26 Temozolomide 23 Doxorubicin 22 Radiotherapy 21 Filgrastim 19 Ifosfamide 15 pazopanib 14 Gemcitabine 14 Etoposide 13 Bevacizumab 13 Irinotecan 12 Cisplatin 12 Magnetic Resonance Spectroscopy 11 Imatinib Mesylate 11 Granulocyte Colony-Stimulating Factor 11 Carboplatin 11 Radiation 9 Methotrexate 9 pembrolizumab 8 fludarabine phosphate 8 Rituximab 8 Paclitaxel 8 Docetaxel 8 Cyclosporine 8 Busulfan 8 Antilymphocyte Serum 8 fludarabine 7 Vincristine 7 Radiotherapy, Intensity-Modulated 7 Mycophenolic Acid 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × nintedanib × Sarcoma × Clear all

NCT02808247 2021-09-20

ANITA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡